XTL BIOPHARMACEUTICALS LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.48 USD | +1.64% |
|
+21.57% | +145.52% |
| 06-05 | XTL Biopharmaceuticals Signs Deal to Acquire The Social Proxy | MT |
| 06-05 | XTL Biopharmaceuticals Ltd. announced that it has received $1.5 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 51.07B | - | |||||
| 38.86B | ||||||
| 38.78B | ||||||
| 26.69B | ||||||
| 26.35B |
